Matches in Wikidata for { <http://www.wikidata.org/entity/Q91154959> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q91154959 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91154959 description "scientific article published on 29 October 2019" @default.
- Q91154959 description "wetenschappelijk artikel" @default.
- Q91154959 description "наукова стаття, опублікована 29 жовтня 2019" @default.
- Q91154959 name "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 name "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 type Item @default.
- Q91154959 label "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 label "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 prefLabel "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 prefLabel "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 P1433 Q91154959-4A6152E7-1063-4C9D-83B8-E7320081B050 @default.
- Q91154959 P1476 Q91154959-C50C24AE-D6C5-42B3-9774-D5ADED6EA794 @default.
- Q91154959 P2093 Q91154959-105D4960-34C8-415F-BA9B-7E5169A8A30F @default.
- Q91154959 P2093 Q91154959-2DCC3049-A2B4-4F4F-86DD-242055B389FA @default.
- Q91154959 P2093 Q91154959-2E77E6FF-02E4-4655-BE7F-245EC8EFCC6F @default.
- Q91154959 P2093 Q91154959-32C86615-1BAC-4A58-B2A7-D1928999845E @default.
- Q91154959 P2093 Q91154959-3C766C0D-7D5A-40AE-8D9A-11B7CA0EE754 @default.
- Q91154959 P2093 Q91154959-3CB8A40F-302F-4CF6-9428-B303C8FA51A3 @default.
- Q91154959 P2093 Q91154959-42A7630B-E9C0-4973-93E2-BA809137FF0B @default.
- Q91154959 P2093 Q91154959-5B3CBF02-1D3F-45D6-B7EC-409CAB662C4E @default.
- Q91154959 P2093 Q91154959-5C37CAE1-155A-46D2-A390-0B0E2B384174 @default.
- Q91154959 P2093 Q91154959-6748AC0D-C4BB-4CC8-A425-0835C3A0B19E @default.
- Q91154959 P2093 Q91154959-9B379642-9B08-433E-97C7-99E4CF03E00B @default.
- Q91154959 P2093 Q91154959-BF7F73EE-5B85-4F57-A68D-AA726436B3E1 @default.
- Q91154959 P2093 Q91154959-BFA99485-7628-4202-869E-B62F9D345B55 @default.
- Q91154959 P2093 Q91154959-D3DAEDD7-D5D0-4DE4-B9CC-126FF399A8FF @default.
- Q91154959 P2093 Q91154959-E942A21A-832E-42AF-9DBB-CB605FBDEBB7 @default.
- Q91154959 P2093 Q91154959-FD9CCE64-41E0-4039-A945-5FD1007B0A3B @default.
- Q91154959 P304 Q91154959-CC013905-182D-4170-A4E0-F390C43C6A4B @default.
- Q91154959 P31 Q91154959-5ADE2BA7-6A2F-4B6C-BD75-1511074189AF @default.
- Q91154959 P356 Q91154959-DC6A431C-B00D-4018-B3F9-A570345A71A4 @default.
- Q91154959 P433 Q91154959-BB228D93-7A00-4364-98FE-4C05D093FD36 @default.
- Q91154959 P478 Q91154959-9C03D11B-AD84-4FAD-93B1-F0D025FBA6DC @default.
- Q91154959 P50 Q91154959-ECCF6662-AD3E-4648-B7F7-1D41BDD51D15 @default.
- Q91154959 P577 Q91154959-9E56DB18-DF1F-46ED-8C98-D1AFC6860D02 @default.
- Q91154959 P698 Q91154959-3B1BF9AC-FA1A-45AA-86F7-00764DB74636 @default.
- Q91154959 P932 Q91154959-5DE571F4-4330-490C-B79C-9DB6F0BAB7FF @default.
- Q91154959 P356 ONCOTARGET.27214 @default.
- Q91154959 P698 31695838 @default.
- Q91154959 P1433 Q1573155 @default.
- Q91154959 P1476 "Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer" @default.
- Q91154959 P2093 "Abhishek Mahajan" @default.
- Q91154959 P2093 "Amit Janu" @default.
- Q91154959 P2093 "Amit Joshi" @default.
- Q91154959 P2093 "Anuradha Chougule" @default.
- Q91154959 P2093 "Arun Chandrasekharan" @default.
- Q91154959 P2093 "Kumar Prabhash" @default.
- Q91154959 P2093 "Nikhil Pande" @default.
- Q91154959 P2093 "Nilendu Purandare" @default.
- Q91154959 P2093 "Rajiv Kumar" @default.
- Q91154959 P2093 "Sadhana Kanan" @default.
- Q91154959 P2093 "Sucheta More" @default.
- Q91154959 P2093 "Supriya Goud" @default.
- Q91154959 P2093 "Vanita Noronha" @default.
- Q91154959 P2093 "Vijai Simha" @default.
- Q91154959 P2093 "Vijay Patil" @default.
- Q91154959 P2093 "Vivek Agarwala" @default.
- Q91154959 P304 "6297-6307" @default.
- Q91154959 P31 Q13442814 @default.
- Q91154959 P356 "10.18632/ONCOTARGET.27214" @default.
- Q91154959 P433 "59" @default.
- Q91154959 P478 "10" @default.
- Q91154959 P50 Q47135182 @default.
- Q91154959 P577 "2019-10-29T00:00:00Z" @default.
- Q91154959 P698 "31695838" @default.
- Q91154959 P932 "6824869" @default.